Dr Reddy's Laboratories Limited
- Address
- Biologics Survey No 47 44 Part Bachupally Village Bachupally Mandal, Medchal Malkajgiri District
Sponsor Overview
Specializations
Rheumatoid Arthritis
Dr Reddy's Laboratories Limited is active in clinical research for rheumatoid arthritis, with studies focused on adults living with moderate to severe inflammatory joint disease who remain symptomatic despite background methotrexate treatment.
- Rheumatology
- Inflammatory arthritis
- Autoimmune disease
The sponsor’s research in this area reflects interest in treatment options for patients with persistent disease activity and prior exposure to conventional or biologic disease-modifying therapies.
Biologic Therapy
The company’s trial portfolio includes research on biologic therapies used in autoimmune disorders, with attention to agents targeting immune-mediated pathways in rheumatoid arthritis.
- Abatacept
- Tocilizumab
- Immune modulation
This area highlights therapeutic interest in biologic options for patients requiring advanced management beyond standard background therapy.
Biosimilar Development
Dr Reddy's Laboratories Limited is also involved in clinical evaluation of biosimilars, with research centered on reference-matched therapies for rheumatologic disease.
- Abatacept biosimilar
- Tocilizumab biosimilar
- Comparative immunogenicity
These studies place emphasis on therapeutic equivalence in immune-mediated inflammatory conditions and broaden access to established biologic treatment classes.
Inflammation and Immune Response
The sponsor’s research interests extend to inflammation and immune system regulation, particularly in settings where chronic immune activation drives joint damage and ongoing symptoms.
- Immune-mediated inflammation
- Joint disease activity
- Therapeutic immunology
Clinical work in this domain supports investigation of targeted treatments for patients with persistent autoimmune inflammatory disease.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| A phase III, randomised, double-blind, multicentre study comparing the efficacy, safety, and immunogenicity of proposed tocilizumab biosimilar (DRL_Tocilizumab) with tocilizumab reference product (RoActemra®) administered by the subcutaneous route as an add-on to methotrexate in the treatment of patients with moderate to severe rheumatoid arthritis |  Bulgaria Czechia Estonia Hungary Lithuania Poland Romania | Not Yet Recruiting |
| Randomized, Double-Blind, Multicenter Study on Efficacy, Safety, and Immunogenicity of Abatacept Biosimilar DRL_AB vs. Abatacept with Methotrexate in Rheumatoid Arthritis | Bulgaria Czechia Estonia Hungary Latvia Lithuania Poland Romania | Not Recruiting |
Data & Insights
This sponsor works with 3 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 76 sites across their trial portfolio.
Therapeutic Focus
- 1.Immune System Diseases2 trials322 other sponsors
Partnered Research Centres
76 centres- Address
- Ulitsa Georgi Kondolov 43a, 4004 Plovdiv
- Address
- Semmelweis Utca 1, 5700 Gyula
- Address
- Ul. Studzienna 35-36/a, 82-300 Elblag
- Address
- Ul. Henryka Sienkiewicza 23, 30-033 Krakow
- Address
- Ul. Ul. Ludwika Solskiego 4a/1, 52-416 Wroclaw
- Address
- Al. Wilanowska 333, 02-665 Warsaw
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Dr Reddy's Laboratories Limited.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.